Upgrade to SI Premium - Free Trial

Roth Capital Reiterates Buy Following Neogen Corp's (NEOG) Mixed 2Q Results

December 22, 2015 8:49 AM
Roth Capital reiterated a Buy rating on Neogen (NASDAQ: NEOG), and raised the price target to $68.00 (from $65.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles